Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Citrin Website

Deborah E. Citrin, M.D.

Selected Publications
1)  Li G, Xie H, Ning H, Citrin D, Capala J, Maass-Moreno R, Guion P, Arora B, Coleman N, Camphausen K, Miller RW.
Accuracy of 3D volumetric image registration based on CT, MR and PET/CT phantom experiments.
Journal of applied clinical medical physics / American College of Medical Physics. 9: 2781, 2008. [Journal]
2)  Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, Kammula U, Robbins PF, Huang J, Citrin DE, Leitman SF, Wunderlich J, Restifo NP, Thomasian A, Downey SG, Smith FO, Klapper J, Morton K, Laurencot C, White DE, Rosenberg SA.
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens.
J. Clin. Oncol. 2008. [Journal]
3)  Citrin D, Mansueti J, Likhacheva A, Sciuto L, Albert PS, Rudy SF, Cooley-Zgela T, Cotrim A, Solomon B, Colevas AD, Russo A, Morris JC, Herscher L, Smith S, Van Waes C.
Long-Term Outcomes and Toxicity of Concurrent Paclitaxel and Radiotherapy for Locally Advanced Head-and-Neck Cancer.
Int. J. Radiat. Oncol. Biol. Phys. 2008. [Journal]
4)  Kirk MJ, Hayward RM, Sproull M, Scott T, Smith S, Cooley-Zgela T, Crouse NS, Citrin DE, Camphausen K.
Non-patient related variables affecting levels of vascular endothelial growth factor in urine biospecimens.
J. Cell. Mol. Med. 12: 1250-5, 2008. [Journal]
5)  Brown AP, Wendler DS, Camphausen KA, Miller FG, Citrin D.
Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations.
J. Clin. Oncol. 26: 3987-94, 2008. [Journal]
6)  Ko C, Citrin D.
Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck.
Oral diseases. 2008. [Journal]
7)  Citrin D, Camphausen K.
Advancement of antiangiogenic and vascular disrupting agents combined with radiation.
Cancer Treat. Res. 139: 153-71, 2008. [Journal]
8)  Li G, Citrin D, Camphausen K, Mueller B, Burman C, Mychalczak B, Miller RW, Song Y.
Advances in 4D Medical Imaging and 4D Radiation Therapy.
Technol. Cancer Res. Treat. 7: 67-82, 2008. [Journal]
9)  Brown AP, Citrin DE, Camphausen KA.
Clinical biomarkers of angiogenesis inhibition.
Cancer Metastasis Rev. 27: 415-34, 2008. [Journal]
10)  Hayward RM, Kirk MJ, Sproull M, Scott T, Smith S, Cooley-Zgela T, Crouse NS, Citrin DE, Camphausen K.
Post-collection,pre-measurement variables affecting VEGF levels in urine biospecimens.
J. Cell. Mol. Med. 12: 343-50, 2008. [Journal]
11)  Kaushal A, Citrin D.
The role of radiation therapy in the management of sarcomas.
Surg. Clin. North Am. 88: 629-46, viii, 2008. [Journal]
12)  Panandiker AP, Ning H, Likhacheva A, Ullman K, Arora B, Ondos J, Karimpour S, Packer R, Miller R, Citrin D.
Craniospinal irradiation with spinal IMRT to improve target homogeneity.
Int J Radiat Oncol Biol Phys. 68: 1402-9, 2007. [Journal]
13)  Kirk MJ, Hayward RM, Sproull M, Scott T, Smith S, Cooley-Zgela T, Crouse NS, Citrin DE, Camphausen K.
Non-patient related variables affecting levels of vascular endothelial growth factor in urine biospecimens.
J Cell Mol Med. Epub ahead of print, 2007. [Journal]
14)  Brown MW, Ning H, Arora B, Albert PS, Poggi M, Camphausen K, Citrin D.
A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma.
Int. J. Radiat. Oncol. Biol. Phys. 65: 274-83, 2006. [Journal]
15)  Ahlers CM, Camphausen K, Citrin D, Arlen PM, Gulley JL.
A pilot trial of a carcinoembryonic antigen/ TRICOM-based vaccine and radiation to liver metastases in patients with carcinoembryonic antigen-positive solid tumors.
Clin Colorectal Cancer. 6: 72-5, 2006. [Journal]
16)  Citrin D, Menard C, Camphausen K.
Combining radiotherapy and angiogenesis inhibitors: clinical trial design.
Int. J. Radiat. Oncol. Biol. Phys. 64: 15-25, 2006. [Journal]
17)  Singh AK, Guion P, Susil RC, Citrin DE, Ning H, Miller RW, Ullman K, Smith S, Crouse NS, Godette DJ, Stall BR, Coleman CN, Camphausen K, Menard C.
Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided High Dose Rate brachytherapy boost.
Radiat Oncol. 1: 28, 2006. [Journal]
18)  Muranski P, Boni A, Wrzesinski C, Citrin DE, Rosenberg SA, Childs R, Restifo NP.
Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?.
Nat Clin Pract Oncol. 3: 668-81, 2006. [Journal]
19)  Camphausen K, Citrin D, Krishna MC, Mitchell JB.
Implications for tumor control during protection of normal tissues with antioxidants.
J. Clin. Oncol. 23: 5455-7, 2005. [Journal]
20)  Citrin D, Ning H, Guion P, Li G, Susil RC, Miller RW, Lessard E, Pouliot J, Huchen X, Capala J, Coleman CN, Camphausen K, Ménard C.
Inverse treatment planning based on MRI for HDR prostate brachytherapy.
Int. J. Radiat. Oncol. Biol. Phys. 61: 1267-75, 2005. [Journal]
21)  Kobayashi H, Reijnders K, English S, Yordanov AT, Milenic DE, Sowers AL, Citrin D, Krishna MC, Waldmann TA, Mitchell JB, Brechbiel MW.
Application of a macromolecular contrast agent for detection of alterations of tumor vessel permeability induced by radiation.
Clin. Cancer Res. 10: 7712-20, 2004. [Journal]
22)  Citrin D, Lee AK, Scott T, Sproull M, Ménard C, Tofilon PJ, Camphausen K.
In vivo tumor imaging in mice with near-infrared labeled endostatin.
Mol. Cancer Ther. 3: 481-8, 2004. [Journal]
23)  Citrin D, Scott T, Sproull M, Menard C, Tofilon PJ, Camphausen K.
In vivo tumor imaging using a near-infrared-labeled endostatin molecule.
Int. J. Radiat. Oncol. Biol. Phys. 58: 536-41, 2004. [Journal]
24)  Citrin D, Camphausen K.
Optical imaging of mice in oncologic research.
Expert Rev Anticancer Ther. 4: 857-64, 2004. [Journal]
25)  Miranda KM, Nims RW, Thomas DD, Espey MG, Citrin D, Bartberger MD, Paolocci N, Fukuto JM, Feelisch M, Wink DA.
Comparison of the reactivity of nitric oxide and nitroxyl with heme proteins. A chemical discussion of the differential biological effects of these redox related products of NOS.
J. Inorg. Biochem. 93: 52-60, 2003. [Journal]
26)  Thomas DD, Miranda KM, Colton CA, Citrin D, Espey MG, Wink DA.
Heme proteins and nitric oxide (NO): the neglected, eloquent chemistry in NO redox signaling and regulation.
Antioxid. Redox Signal. 5: 307-17, 2003. [Journal]
27)  Espey MG, Miranda KM, Thomas DD, Xavier S, Citrin D, Vitek MP, Wink DA.
A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen oxide species.
Ann. N. Y. Acad. Sci. 962: 195-206, 2002. [Journal]
28)  Thomas DD, Miranda KM, Espey MG, Citrin D, Jourd'heuil D, Paolocci N, Hewett SJ, Colton CA, Grisham MB, Feelisch M, Wink DA.
Guide for the use of nitric oxide (NO) donors as probes of the chemistry of NO and related redox species in biological systems.
Meth. Enzymol. 359: 84-105, 2002. [Journal]

This page was last updated on 1/12/2009.